Dr. Elaine Watson
Dr. David J. Argyle
Dr. Elaine Watson will be the new dean of the Ross University School of Veterinary Medicine in St. Kitts, West Indies, and Dr. David J. Argyle succeeded her Nov. 1 as dean of the University of Edinburgh Royal (Dick) School of Veterinary Studies in Scotland. Dr. Watson will succeed Dr. David J. DeYoung, whose retirement was previously announced, on Feb. 1, 2012.
A professor of animal reproduction, Dr. Watson was dean at Edinburgh since 2003. She led a $200 million capital development project to create a teaching facility on the Easter Bush Campus, developed one of the first strategic relationships between a pharmaceutical company and a veterinary school to promote educational and research excellence, and gained $3.2 million in funding for the school's International Center in Animal Welfare Education.
Dr. Watson graduated from the University of Glasgow and has doctorates from Edinburgh and Bristol University. Her positions have included ones at the U.K. Ministry of Agriculture, Fisheries and Food and the University of Pennsylvania. In 1991, she returned to Edinburgh as head of reproduction and, in 1999, was awarded a personal chair in veterinary reproduction. She is a European specialist in equine reproduction and serves on editorial boards of three scientific journals.
Dr. Argyle graduated from the University of Glasgow and entered general practice. He earned his doctorate in oncology and immunology at Glasgow, then joined its Department of Veterinary Clinical Studies. In 2002, he became head of veterinary oncology at the University of Wisconsin-Madison. Returning to the U.K. in 2005, he was appointed to the William Dick Chair of Veterinary Clinical Studies at Edinburgh and has led its Veterinary Cancer Care Center since it opened in 2009.
Dr. Argyle is a European specialist in veterinary oncology, a diplomate of the European College of Veterinary Internal Medicine–Companion Animals in Oncology, and scientific co-editor of the Journal of Veterinary and Comparative Oncology. His research interest is the basic biology of cancer, particularly the role of stem cells and the identification of new biomarkers and targets for therapy.